Variant report
Variant | nsv974111 |
---|---|
Chromosome Location | chr13:90484498-90487010 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr13:90485180-90485241 | GM10248 | blood: | n/a | n/a |
2 | E2F4 | chr13:90486471-90486643 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | EP300 | chr13:90485070-90485449 | A549 | lung: | n/a | n/a |
4 | EP300 | chr13:90486593-90486628 | GM12878 | blood: | n/a | n/a |
5 | EP300 | chr13:90484997-90485509 | A549 | lung: | n/a | n/a |
6 | GTF2F1 | chr13:90485727-90485806 | K562 | blood: | n/a | n/a |
7 | IRF1 | chr13:90485873-90485968 | K562 | blood: | n/a | n/a |
8 | IRF1 | chr13:90486356-90486781 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr13:90486625-90486689 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | SP1 | chr13:90484936-90485514 | A549 | lung: | n/a | n/a |
11 | SP1 | chr13:90484958-90485516 | A549 | lung: | n/a | n/a |
12 | TBL1XR1 | chr13:90485699-90485775 | K562 | blood: | n/a | n/a |
13 | TCF12 | chr13:90485018-90485479 | A549 | lung: | n/a | n/a |
14 | ZMIZ1 | chr13:90485272-90485274 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL7L1P1 | TF binding region |
ENSG00000200733 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534324765 | chr13:90484511-90484512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10507978 | chr13:90484515-90484516 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs143232780 | chr13:90484542-90484543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114914241 | chr13:90484571-90484572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185320978 | chr13:90484583-90484584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188289123 | chr13:90484672-90484673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550368698 | chr13:90484678-90484679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568683394 | chr13:90484691-90484692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557328190 | chr13:90484760-90484761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554171268 | chr13:90484789-90484790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566062155 | chr13:90484807-90484808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372042264 | chr13:90484816-90484817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542594737 | chr13:90484862-90484863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559447587 | chr13:90484937-90484938 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs372542075 | chr13:90484950-90484951 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs9560469 | chr13:90485001-90485002 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs557814847 | chr13:90485046-90485047 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs180762155 | chr13:90485062-90485063 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs375325226 | chr13:90485073-90485074 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs377113350 | chr13:90485076-90485077 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs543533666 | chr13:90485103-90485104 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs56205324 | chr13:90485128-90485129 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs555110327 | chr13:90485159-90485160 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs573764799 | chr13:90485183-90485184 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs541275411 | chr13:90485220-90485221 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs559437612 | chr13:90485307-90485308 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs545212146 | chr13:90485308-90485309 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs186442373 | chr13:90485327-90485328 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs565096936 | chr13:90485330-90485331 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs114453311 | chr13:90485331-90485332 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs531240162 | chr13:90485343-90485344 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs145738343 | chr13:90485352-90485353 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs530584882 | chr13:90485376-90485377 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs192246955 | chr13:90485382-90485383 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs148984119 | chr13:90485384-90485385 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs551038756 | chr13:90485413-90485414 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs34856599 | chr13:90485416-90485417 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs116544031 | chr13:90485430-90485431 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs183679889 | chr13:90485437-90485438 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs566279743 | chr13:90485490-90485491 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs531857189 | chr13:90485500-90485501 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs369459938 | chr13:90485505-90485506 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs41460851 | chr13:90485520-90485521 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs557704210 | chr13:90485581-90485582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374309533 | chr13:90485595-90485596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537108700 | chr13:90485601-90485602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555446154 | chr13:90485609-90485610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573780236 | chr13:90485631-90485632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534559366 | chr13:90485676-90485677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186985267 | chr13:90485730-90485731 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:90480200-90484600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr13:90480400-90484600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:90483200-90485200 | Weak transcription | Fetal Lung | lung |
4 | chr13:90484000-90485000 | Weak transcription | A549 | lung |
5 | chr13:90484600-90485200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr13:90484600-90485400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr13:90485000-90485400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr13:90485000-90486000 | Enhancers | A549 | lung |
9 | chr13:90485200-90485600 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr13:90485200-90485800 | Enhancers | Fetal Lung | lung |